Sleep deficits but no metabolic deficits in premanifest Huntington's disease

Annals of Neurology

Volumn 78, Issue 4, 2015, Pages 630-648

  Lazar, Alpar S ^a   Panin, Francesca ^a,b   Goodman, Anna O G ^a   Lazic, Stanley E ^c   Lazar, Zsolt I ^d   Mason, Sarah L ^a   Rogers, Lorraine ^e   Murgatroyd, Peter R ^f,g   Watson, Laura P E ^f   Singh, Priya ^h   Borowsky, Beth ⁱ   Shneerson, John M ^e   Barker, Roger A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ANGLIA RUSKIN UNIVERSITY   (United Kingdom)

^c NOVARTIS PHARMA AG   (Switzerland)

^d BABE BOLYAI UNIVERSITY   (Romania)

^e PAPWORTH HOSPITAL   (United Kingdom)

^f ADDENBROOKE S HOSPITAL   (United Kingdom)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^h MEDICAL RESEARCH COUNCIL   (United Kingdom)

ⁱ CHDI MANAGEMENT CHDI FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIMETRY; ADULT; APNEA HYPOPNEA INDEX; ARTICLE; BODY COMPOSITION; CALORIMETRY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COGNITIVE DEFECT; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DUAL ENERGY X RAY ABSORPTIOMETRY; ELECTROENCEPHALOGRAPHY; ENERGY EXPENDITURE; FEMALE; HETEROZYGOTE; HUMAN; HUNTINGTON CHOREA; LABORATORY TEST; MALE; METABOLIC DISORDER; MIDDLE AGED; MOOD DISORDER; MOTOR DYSFUNCTION; NEUROPATHOLOGY; POLYSOMNOGRAPHY; PRIORITY JOURNAL; REM SLEEP; SLEEP; SLEEP DISORDER; SLEEP QUALITY; SLEEP TIME; SLEEP WAKING CYCLE; SLOW WAVE SLEEP; THETA RHYTHM; ASYMPTOMATIC DISEASE; COMPLICATION; HUNTINGTON DISEASE; METABOLISM; SLEEP WAKE DISORDERS;

ADULT; ASYMPTOMATIC DISEASES; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; SLEEP WAKE DISORDERS;

EID: 84942370454     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24495     Document Type: Article

References (68)

1. Morrison PJ,. Accurate prevalence and uptake of testing for Huntington's disease. Lancet Neurol 2010; 9: 1147.
2. Harper PS,. The epidemiology of Huntington's disease. Hum Genet 1992; 89: 365-376.
3. Snell RG, MacMillan JC, Cheadle JP, et al., Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nat Genet 1993; 4: 393-397.
4. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993; 72: 971-983.
5. Paulsen JS, Ready RE, Hamilton JM, et al., Neuropsychiatric aspects of Huntington's disease. J Neurol Neurosurg Psychiatry 2001; 71: 310-314.
6. Djousse L, Knowlton B, Cupples LA, et al., Weight loss in early stage of Huntington's disease. Neurology 2002; 59: 1325-1330.
7. Videnovic A, Lazar AS, Barker RA, Overeem S,. 'The clocks that time us'-circadian rhythms in neurodegenerative disorders. Nat Rev Neurol 2014; 10: 683-693.
8. Ross CA, Tabrizi SJ,. Huntington's disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 2011; 10: 83-98.
9. Walker FO,. Huntington's disease. Lancet 2007; 369: 218-228.
10. Goodman AO, Rogers L, Pilsworth S, et al., Asymptomatic sleep abnormalities are a common early feature in patients with Huntington's disease. Curr Neurol Neurosci Rep 2011; 11: 211-217.
11. Fisher SP, Black SW, Schwartz MD, et al., Longitudinal analysis of the electroencephalogram and sleep phenotype in the R6/2 mouse model of Huntington's disease. Brain 2013; 136 (pt 7): 2159-2172.
12. Kantor S, Szabo L, Varga J, et al., Progressive sleep and electroencephalogram changes in mice carrying the Huntington's disease mutation. Brain 2013; 136 (pt 7): 2147-2158.
13. Kudo T, Schroeder A, Loh DH, et al., Dysfunctions in circadian behavior and physiology in mouse models of Huntington's disease. Exp Neurol 2011; 228: 80-90.
14. Lebreton F, Cayzac S, Pietropaolo S, et al., Sleep physiology alterations precede plethoric phenotypic changes in R6/1 Huntington's disease mice. PloS One 2015; 10: e0126972.
15. Loh DH, Kudo T, Truong D, et al., The Q175 mouse model of Huntington's disease shows gene dosage- and age-related decline in circadian rhythms of activity and sleep. PloS One 2013; 8: e69993.
16. Paulsen JS, Long JD, Ross CA, et al., Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study. Lancet Neurol 2014; 13: 1193-1201.
17. Aziz NA, Pijl H, Frolich M, et al., Systemic energy homeostasis in Huntington's disease patients. J Neurol Neurosurg Psychiatry 2010; 81: 1233-1237.
18. Pratley RE, Salbe AD, Ravussin E, Caviness JN,. Higher sedentary energy expenditure in patients with Huntington's disease. Ann Neurol 2000; 47: 64-70.
19. Goodman AO, Murgatroyd PR, Medina-Gomez G, et al., The metabolic profile of early Huntington's disease-a combined human and transgenic mouse study. Exp Neurol 2008; 210: 691-698.
20. Mochel F, Charles P, Seguin F, et al., Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression. PloS One 2007; 2: e647.
21. Politis M, Pavese N, Tai YF, et al., Hypothalamic involvement in Huntington's disease: an in vivo PET study. Brain 2008; 131 (pt 11): 2860-2869.
22. Penney JB Jr, Vonsattel JP, MacDonald ME, et al., CAG repeat number governs the development rate of pathology in Huntington's disease. Ann Neurol 1997; 41: 689-692.
23. Huntington Study Group. Unified Huntington's Disease Rating Scale: reliability and consistency. Mov Disord 1996; 11: 136-142.
24. Nasreddine ZS, Phillips NA, Bedirian V, et al., The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53: 695-699.
25. Benedict RHB, Schretlen D, Groninger L, Brandt J,. The Hopkins verbal learning test-revised: normative data and analysis of interform and test-retest reliability. Clin Neuropsychol 1998; 12: 43-55.
26. Lezak MD, Howieson DB, Bigler ED, Tranel D,. Neuropsychological assessment. Oxford, UK: Oxford University Press, 1995.
27. Reitan RM,. The relation of the trail making test to organic brain damage. J Consult Psychol 1955; 19: 393-394.
28. Smith A,. Symbol digit modalities test: manual. Los Angeles, LA: Western Psychological Services, 1982.
29. Collins LM, Lazic SE, Barker RA,. A retrospective analysis of hand tapping as a longitudinal marker of disease progression in Huntington's disease. BMC Neurol 2014; 14: 35.
30. Hummel T, Sekinger B, Wolf SR, et al., 'Sniffin' sticks': olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses 1997; 22: 39-52.
31. Montgomery SA, Asberg M,. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382-389.
32. Beck AT, Steer RA, Brown GK,. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation, 1996.
33. Clarke DE, Reekum R, Simard M, et al., Apathy in dementia: an examination of the psychometric properties of the apathy evaluation scale. J Neuropsychiatry Clin Neurosci 2007; 19: 57-64.
34. Patton JH, Stanford MS, Barratt ES,. Factor structure of the Barratt impulsiveness scale. J Clin Psychology 1995; 51: 768-774.
35. Horne JA, Ostberg O,. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol 1976; 4: 97-110.
36. Buysse DJ, Reynolds CF III, Monk TH, et al., The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28: 193-213.
37. Weaver TE, Laizner AM, Evans LK, et al., An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep 1997; 20: 835-843.
38. Johns MW,. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14: 540-545.
39. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The report of an American Academy of Sleep Medicine Task Force. Sleep 1999; 22: 667-689.
40. Oliphant TE,. Python for scientific computing. Comput Sci Eng 2007; 9: 10-20.
41. Hunter JD,. Matplotlib: A 2D graphics environment. Comput Sci Eng 2007; 9: 90-95.
42. Lazar AS, Lazar ZI, Biro A, et al., Reduced fronto-cortical brain connectivity during NREM sleep in Asperger syndrome: an EEG spectral and phase coherence study. Clin Neurophysiol 2010; 121: 1844-1854.
43. Ponomareva N, Klyushnikov S, Abramycheva N, et al., Alpha-theta border EEG abnormalities in preclinical Huntington's disease. J Neurol Sci 2014; 344: 114-120.
44. Flint A, Raben A, Blundell JE, Astrup A,. Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord 2000; 24: 38-48.
45. Moore SA, Hallsworth K, Bluck LJ, et al., Measuring energy expenditure after stroke: validation of a portable device. Stroke 2012; 43: 1660-1662.
46. Schofield WN,. Predicting basal metabolic rate, new standards and review of previous work. Hum Nutr Clin Nutr 1985; 39 (suppl 1): 5-41.
47. Cohen J,. Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988.
48. Tabrizi SJ, Langbehn DR, Leavitt BR, et al., Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 2009; 8: 791-801.
49. Barclay NL, Eley TC, Buysse DJ, et al., Diurnal preference and sleep quality: same genes?. A study of young adult twins. Chronobiol Int 2010; 27: 278-296.
50. Yu JH, Yun CH, Ahn JH, et al., Evening chronotype is associated with metabolic disorders and body composition in middle-aged adults. J Clin Endocrinol Metab 2015; 100: 1494-1502.
51. Merikanto I, Lahti T, Kronholm E, et al., Evening types are prone to depression. Chronobiol Int 2013; 30: 719-725.
52. Scullin MK, Bliwise DL,. Sleep, cognition, and normal aging: integrating a half century of multidisciplinary research. Perspect Psychol Sci 2015; 10: 97-137.
53. Briancon-Marjollet A, Weiszenstein M, Henri M, et al., The impact of sleep disorders on glucose metabolism: endocrine and molecular mechanisms. Diabetol Metab Syndr 2015; 7: 25.
54. Stepanski EJ,. Improving the utility of interpreting sleep fragmentation. J Clin Sleep Med 2007; 3: 275-276.
55. Piano C, Losurdo A, Della Marca G, et al., Polysomnographic findings and clinical correlates in huntington disease. a cross-sectional cohort study. Sleep. 2015 Feb 18. pii: sp-00762-14. [Epub ahead of print]
56. Nguyen L, Bradshaw JL, Stout JC, et al., Electrophysiological measures as potential biomarkers in Huntington's disease: review and future directions. Brain Res Rev 2010; 64: 177-194.
57. Pignatelli M, Lebreton F, Cho YH, Leinekugel X,. "Ectopic" theta oscillations and interictal activity during slow-wave state in the R6/1 mouse model of Huntington's disease. Neurobiol Dis 2012; 48: 409-417.
58. Jeantet Y, Cayzac S, Cho YH,. β oscillation during slow wave sleep and rapid eye movement sleep in the electroencephalogram of a transgenic mouse model of Huntington's disease. PloS One 2013; 8: e79509.
59. Feinberg I, Campbell IG,. Longitudinal sleep EEG trajectories indicate complex patterns of adolescent brain maturation. Am J Physiol Regul Integr Comp Physiol 2013; 304: R296-R303.
60. Marzano C, Ferrara M, Curcio G, De Gennaro L,. The effects of sleep deprivation in humans: topographical electroencephalogram changes in non-rapid eye movement (NREM) sleep versus REM sleep. J Sleep Res 2010; 19: 260-268.
61. Dijk DJ, Duffy JF, Riel E, et al., Ageing and the circadian and homeostatic regulation of human sleep during forced desynchrony of rest, melatonin and temperature rhythms. J Physiol 1999; 516 (pt 2): 611-627.
62. Kalliolia E, Silajdzic E, Nambron R, et al., Plasma melatonin is reduced in Huntington's disease. Mov Disord 2014; 29: 1511-1515.
63. Brown RE, Basheer R, McKenna JT, et al., Control of sleep and wakefulness. Physiol Rev 2012; 92: 1087-1187.
64. Saper CB, Scammell TE, Lu J,. Hypothalamic regulation of sleep and circadian rhythms. Nature 2005; 437: 1257-1263.
65. Arnulf I, Nielsen J, Lohmann E, et al., Rapid eye movement sleep disturbances in Huntington disease. Arch Neurol 2008; 65: 482-488.
66. Dijk DJ, Groeger JA, Stanley N, Deacon S,. Age-related reduction in daytime sleep propensity and nocturnal slow wave sleep. Sleep 2010; 33: 211-223.
67. Tononi G, Cirelli C,. Sleep and the price of plasticity: from synaptic and cellular homeostasis to memory consolidation and integration. Neuron 2014; 81: 12-34.
68. Ho AK, Robbins AO, Barker RA,. Huntington's disease patients have selective problems with insight. Mov Disord 2006; 21: 385-389.